Shockwave Medical (SWAV) is attracting takeover interest from Boston Scientific (BSX), Michelle Davis and Dinesh Nair of Bloomberg report, citing people with knowledge of the matter. Boston Scientific has been exploring a potential deal for Shockwave to boost its portfolio of cardiovascular devices, sources told Bloomberg, which reported last year that Shockwave was working with advisers to study mergers or partnerships after receiving takeover interest. Shares of ShockWave are up 7% to $279.08 following the report while Boston Scientific is down 2% to $51.35.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SWAV:
